High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 1, 1999, Pages 91-96

  Yoshizumi, Marc O ^a   Kashani, Amir ^a   Palmer, James ^b   Lee, Grace ^c   Mondino, Bartly ^a  

^a JULES STEIN EYE INSTITUTE   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; METHYLPREDNISOLONE; VANCOMYCIN;

ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CORTICOSTEROID THERAPY; DRUG MEGADOSE; ENDOPHTHALMITIS; EXPERIMENTAL INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 0033007939     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.91     Document Type: Article

References (15)

1. Meredith, T.A., Trabelsi, A., Miller, M.J., Aguilar, E. and Wilson L.A. Spontaneous sterilization in experimental Staphylococcus epidermidis endophthalmitis. Invest. Ophthalmol. Vis. Sci., 31:181-186, 1990.
2. Saez-Llorens, X., Ramilo, O., Mustafa, M.M. and McCracken, G.H. Jr. Molecular pathophysiology of bacterial meningitis: Current concepts and therapeutic implications. J. Fed., 116:671-684, 1990.
3. Quagliarello, V. and Scheld, W.M. Bacterial meningitis: Pathogenesis pathophysiology and progress. N. Engl. J. Med., 327:864-872, 1992.
4. Tuomanen, E. Breaching the blood-brain barrier. Scien. Am., 268:80-84, 1993.
5. Beutler, B., Krochin, N., Milsark, I.W., Leudke, C. and Cerami, A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980, 1986.
6. Kern, J.A., Lamb, R.J., Reed, J.C., Daniele, R.P. and Nowell, P.C. Dexamethasone inhibition of interleukin-1 Beta production by human monocytes. J. Clin. Invest. 81:237-244, 1988.
7. Graham, R.O. and Peyman, G.A. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis. Arch. Ophthalmol. 92:149-154, 1974.
8. Meredith, T.A., Aguilar, H.E., Miller, M.J., Gardner, S.K., Trabelsi, A. and Wilson, L.A. Comparative treatment of experimental Staphylococcus epidermidis endophthalmitis. Arch. Ophthalmol. 108:857-860, 1990.
9. Maxwell, D.P., Brent, B.D., Diamond, J.G. and Leeteh, W.U. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis. Ophthalmology 98:1370-1375, 1991.
10. Mao, L.K., Flynn, H.W., Miller, D. and Pflugfelder, S.C. Endophthalmitis caused by Staphylococcus aureus. Am. J. Ophthalmol. 116:584-589, 1993.
11. Park, S.S., Samiy, N., Ruoff, K., D'Amico, D.J. and Baker, A.S. Effect of intravitreal dexamethasone in the treatment of Pneumococcal endophthalmitis in rabbits. Arch. Ophthalmol. 113:1324-1329, 1995.
12. Jett, B.D., Jensen, H.G., Atkuri, R.V. and Gilmore, M.S. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest. Ophthalmol. Vis. Sci. 36:9-15, 1995.
13. Yoshizumi, M.O., Lee, G.C., Equi, R.A., Kim, I.T., Pitchekian-Halabi, H., Adamu, S.A. and Mondino, B.J. Timing of intravitreal dexamethasone in Staphylococcus aureus endophthalmitis. Retina, 1998 (In press).
14. Aguilar, H.E., Meredith, T.A., Drews, C., Grossniklaus, H., Sawant, A.D. and Gardner, S. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am. J. Ophthalmol. 121:310-317, 1996.
15. Engstrom, R.E., Mondino, B.J., Glasgow, B.J., Pitchekian-Halabi, H. and Adamu, S. Immune response to Staphylococcus aureus endophthalmitis in a rabbit model. Invest. Ophthalmol. Vis. Sci. 32:1523-1533, 1991.